Literature DB >> 31320451

Defective bacterial phagocytosis is associated with dysfunctional mitochondria in COPD macrophages.

Kylie B R Belchamber1, Richa Singh1, Craig M Batista1, Moira K Whyte2, David H Dockrell2, Iain Kilty3, Matthew J Robinson4, Jadwiga A Wedzicha1, Peter J Barnes1, Louise E Donnelly5.   

Abstract

Increased reactive oxygen species (ROS) have been implicated in the pathophysiology of chronic obstructive pulmonary disease (COPD). This study examined the effect of exogenous and endogenous oxidative stress on macrophage phagocytosis in patients with COPD.Monocyte-derived macrophages (MDMs) were generated from non-smoker, smoker and COPD subjects, differentiated in either granulocyte macrophage-colony stimulating factor (G-Mφ) or macrophage-colony stimulating factor (M-Mφ). Alveolar macrophages were isolated from lung tissue or bronchoalveolar lavage fluid. Macrophages were incubated in ±200 µM H2O2 for 24 h, then exposed to fluorescently labelled Haemophilus influenzae or Streptococcus pneumoniae for 4 h, after which phagocytosis, mitochondrial ROS (mROS) and mitochondrial membrane potential (ΔΨm) were measured.Phagocytosis of bacteria was significantly decreased in both G-Mφ and M-Mφ from COPD patients compared with from non-smoker controls. In non-smokers and smokers, bacterial phagocytosis did not alter mROS or ΔΨm; however, in COPD, phagocytosis increased early mROS and decreased ΔΨm in both G-Mφ and M-Mφ. Exogenous oxidative stress reduced phagocytosis in non-smoker and COPD alveolar macrophages and non-smoker MDMs, associated with reduced mROS production.COPD macrophages show defective phagocytosis, which is associated with altered mitochondrial function and an inability to regulate mROS production. Targeting mitochondrial dysfunction may restore the phagocytic defect in COPD.
Copyright ©ERS 2019.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31320451     DOI: 10.1183/13993003.02244-2018

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  33 in total

Review 1.  Mitochondria: at the crossroads of regulating lung epithelial cell function in chronic obstructive pulmonary disease.

Authors:  Mahyar Aghapour; Alexander H V Remels; Simon D Pouwels; Dunja Bruder; Pieter S Hiemstra; Suzanne M Cloonan; Irene H Heijink
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-11-06       Impact factor: 5.464

2.  Alveolar Macrophage Immunometabolism and Lung Function Impairment in Smoking and Chronic Obstructive Pulmonary Disease.

Authors:  Sarah L O'Beirne; Sarah Ann Kikkers; Clara Oromendia; Jacqueline Salit; Mahboubeh R Rostmai; Karla V Ballman; Robert J Kaner; Ronald G Crystal; Suzanne M Cloonan
Journal:  Am J Respir Crit Care Med       Date:  2020-03-15       Impact factor: 21.405

3.  A risk score for predicting hospitalization for community-acquired pneumonia in ITP using nationally representative data.

Authors:  Ye-Jun Wu; Ming Hou; Hui-Xin Liu; Jun Peng; Liang-Ming Ma; Lin-Hua Yang; Ru Feng; Hui Liu; Yi Liu; Jia Feng; Hong-Yu Zhang; Ze-Ping Zhou; Wen-Sheng Wang; Xu-Liang Shen; Peng Zhao; Hai-Xia Fu; Qiao-Zhu Zeng; Xing-Lin Wang; Qiu-Sha Huang; Yun He; Qian Jiang; Hao Jiang; Jin Lu; Xiang-Yu Zhao; Xiao-Su Zhao; Ying-Jun Chang; Lan-Ping Xu; Yue-Ying Li; Qian-Fei Wang; Xiao-Hui Zhang
Journal:  Blood Adv       Date:  2020-11-24

Review 4.  Biology of lung macrophages in health and disease.

Authors:  Helena Aegerter; Bart N Lambrecht; Claudia V Jakubzick
Journal:  Immunity       Date:  2022-09-13       Impact factor: 43.474

Review 5.  Recent evidence from omic analysis for redox signalling and mitochondrial oxidative stress in COPD.

Authors:  Sharon Mumby; Ian M Adcock
Journal:  J Inflamm (Lond)       Date:  2022-07-11       Impact factor: 6.283

Review 6.  Role of Metabolic Reprogramming in Pulmonary Innate Immunity and Its Impact on Lung Diseases.

Authors:  Charalambos Michaeloudes; Pankaj K Bhavsar; Sharon Mumby; Bingling Xu; Christopher Kim Ming Hui; Kian Fan Chung; Ian M Adcock
Journal:  J Innate Immun       Date:  2019-11-29       Impact factor: 7.349

7.  Association of urine mitochondrial DNA with clinical measures of COPD in the SPIROMICS cohort.

Authors:  William Z Zhang; Michelle C Rice; Katherine L Hoffman; Clara Oromendia; Igor Z Barjaktarevic; J Michael Wells; Annette T Hastie; Wassim W Labaki; Christopher B Cooper; Alejandro P Comellas; Gerard J Criner; Jerry A Krishnan; Robert Paine; Nadia N Hansel; Russell P Bowler; R Graham Barr; Stephen P Peters; Prescott G Woodruff; Jeffrey L Curtis; Meilan K Han; Karla V Ballman; Fernando J Martinez; Augustine Mk Choi; Kiichi Nakahira; Suzanne M Cloonan; Mary E Choi
Journal:  JCI Insight       Date:  2020-02-13

8.  Update in Chronic Obstructive Pulmonary Disease 2020.

Authors:  Andy I Ritchie; Jonathon R Baker; Trisha M Parekh; James P Allinson; Surya P Bhatt; Louise E Donnelly; Gavin C Donaldson
Journal:  Am J Respir Crit Care Med       Date:  2021-07-01       Impact factor: 21.405

Review 9.  ACO (Asthma-COPD Overlap) Is Independent from COPD, a Case in Favor: A Systematic Review.

Authors:  Naoya Fujino; Hisatoshi Sugiura
Journal:  Diagnostics (Basel)       Date:  2021-05-11

10.  Pneumolysin Is Responsible for Differential Gene Expression and Modifications in the Epigenetic Landscape of Primary Monocyte Derived Macrophages.

Authors:  Joby Cole; Adrienn Angyal; Richard D Emes; Tim John Mitchell; Mark J Dickman; David H Dockrell
Journal:  Front Immunol       Date:  2021-05-11       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.